Loading...
XHKG
1498
Market cap18mUSD
Dec 05, Last price  
0.37HKD
1D
1.37%
1Q
-16.85%
Jan 2017
-90.11%
IPO
-92.16%
Name

PuraPharm Corp Ltd

Chart & Performance

D1W1MN
XHKG:1498 chart
P/E
P/S
0.38
EPS
Div Yield, %
Shrs. gr., 5y
7.43%
Rev. gr., 5y
-11.30%
Revenues
382m
-6.09%
342,303,000366,352,000473,900,000535,986,000591,566,000745,503,000695,879,000601,815,000659,592,000448,069,000406,859,000382,090,000
Net income
-35m
L-66.59%
26,264,00034,463,00028,458,00032,162,0001,889,00020,806,000-227,258,00031,710,000-121,877,000-120,214,000-106,081,000-35,439,000
CFO
104m
+30.62%
11,034,00031,091,000-12,570,000-55,828,000-42,752,00072,461,000101,935,00086,682,000-39,327,00065,848,00079,608,000103,985,000
Dividend
May 31, 20170.0202 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

PuraPharm Corporation Limited, an investment holding company, researches, develops, produces, and sells concentrated Chinese medicine granule (CCMG) and Chinese healthcare products in Hong Kong, Mainland China, and internationally. It operates through five segments: China CCMG, Hong Kong CCMG, Chinese Healthcare Products, Clinics, and Plantation. The company offers over the counter health products under the PuraGold, Haveron, Oncozac, and Immuzac names. It also provides Chinese medicine clinic management system for general clinic management; and operates Chinese medicine clinics under the Nong's name that provide Chinese medicine services and concentrated Chinese medicine granules products. In addition, the company engages in the plantation and trading of raw Chinese herbs; and manufacture and sale of traditional Chinese medicine decoction pieces. Further, it provides modernized Chinese medicine services; and Chinese medical diagnostic services. The company sells its products to hospitals, healthcare institutions, and medicine practitioners, as well as operates an online store. It operates 43 Nong's clinics in Hong Kong and 1 Nong's clinic in Guangxi, China. The company was founded in 1998 and is headquartered in Tai Po, Hong Kong.
IPO date
Jul 08, 2015
Employees
650
Domiciled in
HK
Incorporated in
KY

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT